Alyeska Investment Group’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,000	Closed	-$508K	–	832
2021 Q1	$508K	Sell	25,000 -25,000	-50%	-$508K	0.01%	654
2020 Q4	$1.33M	Sell	50,000 -400	-0.8%	-$10.6K	0.02%	394
2020 Q3	$1.13M	Buy	+50,400	New	+$1.13M	0.02%	379